口腔医学 ›› 2024, Vol. 44 ›› Issue (6): 452-457.doi: 10.13591/j.cnki.kqyx.2024.06.010

• 综述 • 上一篇    下一篇

牙髓干细胞治疗糖尿病的研究进展

黄蔼岚1,郭培培1,陆晓庆2,吴锦涛3,李泽汉3,徐秀清3,王娟3,周莉丽3()   

  1. 1 南京医科大学口腔医学院口腔内科学系,江苏南京(210029)
    2 南京医科大学附属口腔医院教学办公室,江苏省口腔转化医学工程研究中心,江苏南京(210029)
    3 南京医科大学附属口腔医院牙体牙髓病科,江苏省口腔疾病研究重点实验室,江苏省口腔转化医学工程研究中心,江苏南京(210029)
  • 收稿日期:2023-08-16 出版日期:2024-06-28 发布日期:2024-06-27
  • 通讯作者: 周莉丽 E-mail:zhoulili625@njmu.edu.cn
  • 基金资助:
    国家自然科学基金(82201024);中华口腔医学会青年科研基金树脂材料研究项目(CSA-R2018-10)

Progress and prospects of dental pulp stem cells in diabetes treatment

HUANG Ailan1,GUO Peipei1,LU Xiaoqing2,WU Jintao3,LI Zehan3,XU Xiuqing3,WANG Juan3,ZHOU Lili3()   

  1. Department of Oral Medicine,School of Stomatology,Nanjing Medical University, Nanjing 210029,China
  • Received:2023-08-16 Online:2024-06-28 Published:2024-06-27

摘要:

糖尿病(diabetes mellitus,DM)是一种以高血糖为主要特征的慢性代谢性疾病,由胰岛素抵抗或胰岛素分泌异常引起,因胰岛β细胞的破坏导致患者持续高血糖,可诱导多发性神经病变等并发症,患病率与死亡率均较高。牙髓干细胞(dental pulp stem cells,DPSCs)获取容易,具有自我更新、多向分化及高度增殖的能力,可被诱导分化为胰岛β细胞参与胰岛素分泌和免疫调节,在慢性疾病的治疗中取得了一定成果。此外,DPSCs还可通过抑制自身免疫、调节炎症及抗氧化应激等途径改善1型糖尿病患者症状。本文综述了DPSCs的生物学特性并探究其通过对DM及其并发症治疗不同机制,以期完善DM管理。

关键词: 牙髓干细胞, 糖尿病, 胰岛素, 并发症, 免疫调节

Abstract:

Diabetes mellitus (DM) stands as a chronic metabolic ailment predominantly characterized by elevated blood glucose levels, stemming from either a resistance to insulin or aberrations in insulin secretion. The ensuing persistent hyperglycemia, a direct consequence of pancreatic β-cell devastation, acts as a catalyst for a myriad of complications, inclusive of extensive neuropathies. The disease has substantial prevalence and mortality rates, underscoring the gravity of its impact on public health. Dental pulp stem cells (DPSCs) are readily obtainable, and they exhibit a profound capacity for self-renewal, multi-lineage differentiation, and vigorous proliferation. Remarkably, DPSCs can differentiate into pancreatic β-cells, subsequently participate in insulin secretion and play a pivotal role in immune modulation. This has achieved notable advancements in the therapeutic domain, particularly in the treatment of chronic diseases. Furthermore, DPSCs harbor the potential to mitigate symptoms in patients afflicted with type 1 diabetes. They navigate this therapeutic pathway through mechanisms that involve suppressing autoimmunity, modulating inflammatory responses, and counteracting oxidative stress. This article meticulously reviews the biological characteristics inherent to DPSCs and explores their multifaceted therapeutic potential in addressing DM and its associated complications. Through this endeavor, the article aims to contribute to the refinement and enhancement of DM management strategies.

Key words: dental pulp stem cells, diabetes mellitus, insulin, complication, immunoregulation

中图分类号: